The cosmetics industry is undergoing its most significant transformation in decades, driven by educated consumers, social media influencers, an indie brand explosion, and the toughest federal regulation the category has ever faced. At the center of that transformation, contract manufacturers like Bright Innovation Labs are doing far more than a simple mix and fill. Nowhere is this expanded role more evident than in Bright Innovation Labs’ Contract Manufacturing R&D operation, where chemists and formulators work alongside clients from the earliest concept conversations through final commercial launch.
“We are sitting on a cosmetic revolution,” says Eric Adu, Director of R&D at Bright Innovation Labs’ CMO headquarters in New Albany, Ohio. “In the past, cosmetics was just creating a product, and there wasn’t too much to it. Today the industry has grown to the point where consumers are more aware of their products, the regulation is changing, and brands have to listen.”
Adu, who has watched the industry shift across his eight years in R&D leadership, describes today’s contract manufacturing mandate as fundamentally different from a decade ago. “It is not just being creative. It is being skillful at converting marketing concepts into a scalable, regulatory-compliant, consumer-friendly, commercially viable product. That is the challenge people like myself in the industry are seeing.”
He breaks the transformation into five interconnected forces.
The Consumer Has the Microphone
The first and most powerful change, according to Adu, is the consumer. Where shoppers once relied on television advertisements and supermarket displays for product information, today they bring smartphones, scanner apps, influencer recommendations, and ingredient databases to every purchase decision.
“Influencers have a big role to play in the industry now because they have the microphone and people are listening,” Adu says. “If an influencer takes a brand and starts talking bad about it, and other influencers start speaking on that, that will be the end of your brand.”
Apps that evaluate ingredient lists have become increasingly influential in shaping consumer perceptions and purchasing decisions. While these tools provide consumers with quick access to product information, they often lack the scientific context needed to fully evaluate ingredient safety, functionality, and overall formulation performance.
As a result, brands and formulators are increasingly navigating the tension between consumer perception and formulation science. In some cases, product teams may explore reformulation opportunities to align with ingredient-rating platforms, even when the ingredients being evaluated have a long history of safe and effective use within established industry standards.
The challenge is that many of these platforms assess ingredients in isolation, without considering factors such as usage levels, formulation design, performance requirements, or the role an ingredient plays in maintaining product quality and stability. While consumer transparency is important, formulation decisions ultimately require a broader view that balances perception, safety, efficacy, and product integrity.
“For me, the conversation always comes back to responsibility,” Adu says. “Consumers want products that are safe, effective, and aligned with their values, and brands want to meet those expectations. Our role as formulators is to help bridge that gap with science. We have to evaluate not only how an ingredient is perceived, but what function it serves and what impact its removal may have on the overall product.”
As consumer awareness continues to evolve, successful product development will require brands and formulation partners to balance market preferences with sound formulation principles. In some cases, that may lead to reformulation; in others, it may involve helping consumers better understand the science behind ingredient choices. “It’s important that we listen to what consumers are asking for,” Adu adds, “but it’s equally important that we continue to apply the scientific expertise that ensures products remain safe, effective, stable, and capable of delivering the experience consumers expect.”
Indie Brands and the Rise of Contract Manufacturing
The second force reshaping cosmetics is the explosion of indie brands, many founded by social media influencers and celebrities. These small, agile teams launch products that established companies cannot or will not.
“The larger brands can’t always move as fast because they already have products on the shelf and in the pipeline,” Adu says. “Indie brands typically have fewer products to manage, so they can react much faster to changing consumer preferences and what people are seeing and talking about on social media.”
That speed advantage has fueled a parallel boom in contract manufacturing. Most indie founders do not own production facilities, and they do not need to.
“People partner with our company to build their own indie brand, to build their own small brand, and then put it on markets like Amazon,” Adu says.
Platforms like Amazon, TikTok Shop, and Shopify have lowered the barriers to entry, making it possible for brands to launch and scale without owning manufacturing assets.
FDA Steps In: The MOCRA Era
For most of modern history, cosmetics operated under a relatively light federal regulatory framework compared with other consumer product categories.
That changed in 2022 with the passage of the Modernization of Cosmetics Regulation Act, known as MOCRA. The law introduces facility registration, mandatory product listing, adverse event reporting, safety substantiation requirements while significantly expanding FDA oversight and establishing a framework for cosmetic Good Manufacturing Practice (cGMP).
The regulatory shift reflects what formulators have been doing on the bench for years. As consumers increasingly seek products that deliver measurable benefits, cosmetic formulations have become more sophisticated, incorporating ingredients once associated primarily with OTC and therapeutic products.
“Cosmetic manufacturers are now having to do more and more to deliver benefits,” Adu says. “We have to use the same active ingredients that OTC or drug manufacturers are using. You have ceramides, ascorbic acid, vitamin C, vitamin D – these vitamins being incorporated into products.”
When formulations behave more like drugs and the line between beauty and wellness continue to blur, regulators respond accordingly. Adu welcomes the change. “Regulations are good to protect the consumers, to make sure that the consumers are safe,” he says.
Looking ahead, he believes the distinction between cosmetics and OTC products will continue to narrow. “I am seeing that cosmetics companies and OTC are going to merge at some point, because they are essentially doing the same thing,” Adu says. After all, consumers increasingly expect products that not only delight the senses but also deliver measurable results.
How Bright Innovates With Clients
The combined pressure of consumer scrutiny, regulatory expansion, and competitive speed has reshaped how contract manufacturers approach innovation. At Bright Innovation Labs, that has meant integrating regulatory expertise directly into the bench science, deploying AI tools alongside chemists, and treating raw material vendors as innovation partners.
Regulatory specialists now sit beside chemists from day one. “When my chemists are working, they are collaborating with a regulatory manager who has knowledge of the industry standards and understands the requirements of the market where the products are sold,” Adu says. “As we are selecting the raw materials, we are consulting the regulatory authorities from the very beginning to make sure there are no red flags for the markets we are targeting.”
Technology has become the second pillar of BIL’s approach. “We are forced to use technology to our advantage, because the speed to market has changed significantly,” Adu says. “No longer do we have nine months to develop a product.”
BIL’s chemists use AI platforms such as Potion AI and WorldOver to accelerate formulation research, alongside general-purpose AI tools to evaluate ingredient attributes, claims support, and emerging raw material trends. “We are more intentional in selecting our raw materials,” Adu says, “because the demand from the consumer is high and we have to meet those demands.”
The third pillar is upstream collaboration with raw material suppliers. “Who better to market the raw materials we are using than the one that makes it?” Adu says. “It is in their interest to share the marketing claims they have done, so we see what they have done to substantiate the claims we want to make.”
BIL also pushes its suppliers to develop new ingredients. “We are guiding them. We say, ‘Give us more new textures, something playful, something new in the industry.’ Innovation is not just the product itself. We have to drive innovation at the raw material level to obtain that new claim, that new feature that will drive the market and make the consumer happy.”
The R&D team supplements all of these efforts with on-the-ground intelligence at industry events. “We are traveling to trade shows to make sure every single new technology being featured, we are there learning,” Adu says. “We are on the forefront of learning everything so we can bring it back and stay in tune with the whole movement.”
The Road Ahead
For Adu, the implication is clear. The brands that thrive in this new landscape will be the ones partnered with manufacturers who can navigate every dimension of the revolution at once: scientific, regulatory, technological, and cultural.
“All these parts are moving,” he says, “and our responsibility as industry leaders is to manage them and still create something that will be viable on the market.”